{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:59:06Z","timestamp":1789905546866,"version":"4.0.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1124\/jpet.300.2.559","type":"journal-article","created":{"date-parts":[[2003,7,27]],"date-time":"2003-07-27T00:50:36Z","timestamp":1059267036000},"page":"559-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Immunopharmacological Potential of Selective Phosphodiesterase Inhibition. I. Differential Regulation of Lipopolysaccharide-Mediated Proinflammatory Cytokine (Interleukin-6 and Tumor Necrosis Factor-\u03b1) Biosynthesis in Alveolar Epithelial Cells"],"prefix":"10.1016","volume":"300","author":[{"given":"John J.","family":"Haddad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Land","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William O.","family":"Tarnow-Mordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Zembala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Kowalczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Lauterbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.300.2.559_bib1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s004240050817","article-title":"Activation of wild-type and \u0394F508-CFTR by phosphodiesterase inhibitors through cAMP-dependent and -independent mechanisms.","volume":"437","author":"Al-Nakkash","year":"1999","journal-title":"Pfluegers Arch"},{"key":"10.1124\/jpet.300.2.559_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0022-3565(24)37221-0","article-title":"SB-207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions.","volume":"284","author":"Barnette","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.559_bib3","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.3022382","article-title":"Diminished response of Werner\u2019s syndrome fibroblasts to growth factors PDGF and FGF.","volume":"234","author":"Bauer","year":"1986","journal-title":"Science (Wash DC)"},{"key":"10.1124\/jpet.300.2.559_bib4","first-page":"379","article-title":"Cachectin: more than a tumor necrosis factor.","volume":"316","author":"Beutler","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.300.2.559_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0022-3565(24)35335-2","article-title":"Anti-inflammatory activities of a new series of selective phosphodiesterase 4 inhibitors derived from 9-benzyladenine.","volume":"292","author":"Boichot","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.559_bib6","first-page":"6558","article-title":"A family of human phosphodiesterases homologues to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs.","volume":"13","author":"Bolger","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.300.2.559_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1126\/science.184.4132.19","article-title":"Modulation of inflammation and immunity by cyclic AMP.","volume":"184","author":"Bourne","year":"1972","journal-title":"Science (Wash DC)"},{"key":"10.1124\/jpet.300.2.559_bib8","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.bjp.0702387","article-title":"The effects of phosphodiesterase type 4 inhibitors on tumor necrosis factor-\u03b1 and leukotriene B4 in a novel human whole blood assay.","volume":"126","author":"Brideau","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.300.2.559_bib9","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1164\/ajrccm\/148.5.1174","article-title":"Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome.","volume":"148","author":"Bunnell","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/jpet.300.2.559_bib10","first-page":"783","article-title":"A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery.","volume":"81","author":"Butterworth","year":"1995","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.300.2.559_bib11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1164\/ajrccm\/139.2.370","article-title":"Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis.","volume":"139","author":"Cantin","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/jpet.300.2.559_bib12","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.274.20.13729","article-title":"Cyclic GMP phosphodiesterase-5: target of sildenafil.","volume":"274","author":"Cobrin","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.300.2.559_bib13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.bjp.0702601","article-title":"Pharmacological modulation of secondary mediator systems\u2013cyclic AMP and cyclic GMP\u2013on inflammatory hyperalgesia.","volume":"127","author":"Cunha","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.300.2.559_bib14","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1074\/jbc.272.11.6823","article-title":"Structure, localization and regulation of cGMP-inhibited phosphodiesterase (PDE3).","volume":"272","author":"Degerman","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.300.2.559_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1517\/13543776.5.5.417","article-title":"Cyclic nucleotide phosphodiesterase inhibitors.","volume":"5","author":"Demoliou-Mason","year":"1995","journal-title":"Exp Opin Ther Patents"},{"key":"10.1124\/jpet.300.2.559_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1399-3038.1996.tb00398.x","article-title":"Mechanisms of airway inflammation in cystic fibrosis.","volume":"7","author":"Doring","year":"1996","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1124\/jpet.300.2.559_bib17","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1164\/ajrccm.160.3.9809120","article-title":"The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation.","volume":"160","author":"Dukarm","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.300.2.559_bib18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/sj.bjp.0702124","article-title":"Effect of DMPPO, a phosphodiesterase type 5 inhibitor, on hypoxic pulmonary hypertension in rats.","volume":"125","author":"Eddahibi","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.300.2.559_bib19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1172\/JCI115904","article-title":"Pentoxifylline inhibits interleukin-2-induced toxicity in C57BL\/6 mice but preserves anti-tumor efficacy.","volume":"90","author":"Edwards","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.300.2.559_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(00)00116-3","article-title":"Effects of the phosphodiesterase 4 inhibitor RPR 73401 in a model of immunological inflammation.","volume":"392","author":"Ehinger","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.300.2.559_bib21","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.4049\/jimmunol.159.3.1520","article-title":"Differential expression of cyclic nucleotide phosphodiesterase 3 and 4 activities in human T cell clones specific for myelin basic protein.","volume":"159","author":"Ekholm","year":"1997","journal-title":"J Immunol"},{"key":"10.1124\/jpet.300.2.559_bib22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.2916128","article-title":"Over-expression of transforming growth factor \u03b1 in psoriatic epidermis.","volume":"243","author":"Elder","year":"1989","journal-title":"Science (Wash DC)"},{"key":"10.1124\/jpet.300.2.559_bib23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0006-2952(98)00331-1","article-title":"Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation.","volume":"57","author":"Essayan","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.300.2.559_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","article-title":"Anti-TNF-\u03b1 of rheumatoid arthritis: what have we learned?","volume":"19","author":"Feldmann","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1124\/jpet.300.2.559_bib25","first-page":"1","article-title":"Oxidant injury to the alveolar epithelium: biochemical and pharmacologic studies.","volume":"54","author":"Freeman","year":"1993","journal-title":"Res Rep Health Eff Inst"},{"key":"10.1124\/jpet.300.2.559_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0014-2999(00)00096-0","article-title":"A novel dual regulator of tumor necrosis factor-\u03b1 and interleukin-10 protects mice from endotoxin-induced shock.","volume":"391","author":"Fukuda","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.300.2.559_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0955-0674(99)80028-3","article-title":"Organization and regulation of mitogen-activated protein kinase signaling pathways.","volume":"11","author":"Garrington","year":"1999","journal-title":"Curr Opin Cell Biol"},{"key":"10.1124\/jpet.300.2.559_bib28","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0022-3565(24)39283-3","article-title":"Pentoxifylline ameliorates cerulein-induced pancreatitis in rats: role of glutathione and nitric oxide.","volume":"293","author":"G\u00f3mez-Cambronero","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.559_bib29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0022-3565(24)37847-4","article-title":"SB-207499 (Ariflo), a second-generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor \u03b1 and interleukin-4 production in vivo.","volume":"287","author":"Griswold","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.559_bib30","first-page":"1070","article-title":"VX-745 Vertex Pharmaceuticals.","volume":"2","author":"Haddad","year":"2001","journal-title":"Curr Opin Invest Drugs"},{"key":"10.1124\/jpet.300.2.559_bib31","doi-asserted-by":"crossref","first-page":"L492","DOI":"10.1152\/ajplung.2000.278.3.L492","article-title":"O2-evoked regulation of HIF-1 \u03b1 and NF-\u03ba B in perinatal lung epithelium requires glutathione biosynthesis.","volume":"278","author":"Haddad","year":"2000","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/jpet.300.2.559_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1006\/bbrc.2000.2607","article-title":"The differential expression of apoptosis factors in the alveolar epithelium is redox sensitive and requires NF-\u03baB (RelA)-selective targeting.","volume":"271","author":"Haddad","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.300.2.559_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/bj3550029","article-title":"\u03b1-Melanocyte-related tripeptide, Lys-D-Pro-Val, ameliorates endotoxin-induced nuclear factor \u03baB translocation and activation: evidence for involvement of an interleukin-1\u03b2193\u2013195 receptor antagonism in the alveolar epithelium.","volume":"355","author":"Haddad","year":"2001","journal-title":"Biochem J"},{"key":"10.1124\/jpet.300.2.559_bib34","doi-asserted-by":"crossref","first-page":"21130","DOI":"10.1074\/jbc.M000737200","article-title":"Antioxidant\/pro-oxidant equilibrium regulates HIF-1\u03b1 and NF-\u03baB redox sensitivity Evidence for inhibition by glutathione oxidation in alveolar epithelial cells.","volume":"275","author":"Haddad","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.300.2.559_bib35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/cyto.2000.0789","article-title":"Chemioxyexcitation (\u0394p O2\/ROS) dependent release of IL-1\u03b2, IL-6 and TNF-\u03b1: evidence of cytokines as oxygen-sensitive mediators in the alveolar epithelium.","volume":"13","author":"Haddad","year":"2001","journal-title":"Cytokine"},{"key":"10.1124\/jpet.300.2.559_bib36","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0022-3565(24)38844-5","article-title":"Thiol regulation of pro-inflammatory cytokines reveals a novel immunopharmacological potential of glutathione in the alveolar epithelium.","volume":"296","author":"Haddad","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.559_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.bjp.0704041","article-title":"The biphasic immunoregulation of pyrimidylpiperazine (Y-40138) is IL-10 sensitive and requires NF-\u03baB targeting in the alveolar epithelium.","volume":"133","author":"Haddad","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.300.2.559_bib38","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<468::AID-IMMU468>3.0.CO;2-Z","article-title":"Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL-10 independent.","volume":"28","author":"Hask\u00f3","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1124\/jpet.300.2.559_bib39","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4049\/jimmunol.164.2.1013","article-title":"Inosine inhibits inflammatory cytokine production by a post-transcriptional mechanism and protects against endotoxin-induced shock.","volume":"164","author":"Hask\u00f3","year":"2000","journal-title":"J Immunol"},{"key":"10.1124\/jpet.300.2.559_bib40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0014-2999(00)00866-9","article-title":"A novel anti-rheumatic drug suppresses tumor necrosis factor-\u03b1 and augments interleukin-10 in adjuvant arthritic rats.","volume":"409","author":"Hisadome","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.300.2.559_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0968-0004(97)01050-5","article-title":"Tailoring cAMP-signalling responses through isoform multiplicity.","volume":"22","author":"Houslay","year":"1997","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/jpet.300.2.559_bib42","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.4049\/jimmunol.163.5.2836","article-title":"Regulation of IL-15-stimulated TNF-\u03b1 production by rolipram.","volume":"163","author":"Kasyapa","year":"1999","journal-title":"J Immunol"},{"key":"10.1124\/jpet.300.2.559_bib43","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1164\/ajrccm\/141.3.765","article-title":"Cytokines of the lung.","volume":"141","author":"Kelley","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/jpet.300.2.559_bib44","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1165\/ajrcmb.13.6.7576703","article-title":"CFTR-mediated chloride permeability is regulated by type III phosphodiesterases in airway epithelial cells.","volume":"13","author":"Kelley","year":"1995","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/jpet.300.2.559_bib45","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1164\/ajrccm.160.5.9901097","article-title":"Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barriers in rabbits.","volume":"160","author":"Laffon","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.300.2.559_bib46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000244146","article-title":"Effect of pentoxifylline on nitric oxide released by murine macrophages.","volume":"67","author":"Lauterbach","year":"1995","journal-title":"Biol Neonate"},{"key":"10.1124\/jpet.300.2.559_bib47","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00003246-199904000-00042","article-title":"Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial.","volume":"27","author":"Lauterbach","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.300.2.559_bib48","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/BF01955273","article-title":"Pentoxifylline reduces plasma tumor necrosis factor-\u03b1 concentration in premature infants with sepsis.","volume":"155","author":"Lauterbach","year":"1996","journal-title":"Eur J Pediatr"},{"key":"10.1124\/jpet.300.2.559_bib49","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s004310051158","article-title":"Nebulized pentoxifylline in successful treatment of five premature neonates with bronchopulmonary dysplasia.","volume":"158","author":"Lauterbach","year":"1999","journal-title":"Eur J Pediatr"},{"key":"10.1124\/jpet.300.2.559_bib50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0031-6997(24)01457-1","article-title":"Guanylyl cyclases and signaling by cyclic GMP.","volume":"52","author":"Lucas","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.300.2.559_bib51","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.bjp.0702911","article-title":"Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B.","volume":"128","author":"Manning","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.300.2.559_bib52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0162-3109(00)00249-6","article-title":"Differential effects of pentoxifylline, a non-specific phosphodiesterase inhibitor, on the production of IL-10, IL-12 p40 and p35 subunits by murine peritoneal macrophages.","volume":"49","author":"Marcikiewicz","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1124\/jpet.300.2.559_bib53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0272-5231(05)70160-X","article-title":"Alveolar epithelial barrier: role in lung fluid balance in clinical lung injury.","volume":"21","author":"Matthay","year":"2000","journal-title":"Clin Chest Med"},{"key":"10.1124\/jpet.300.2.559_bib54","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/00003246-199606000-00001","article-title":"Targeting the alveolar epithelium in acute lung injury: keratinocyte growth factor and regulation of the alveolar epithelial barrier.","volume":"24","author":"Matuschak","year":"1996","journal-title":"Crit Care Med"},{"key":"10.1124\/jpet.300.2.559_bib55","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/thx.48.6.660","article-title":"Cytokines: overview.","volume":"48","author":"Nicod","year":"1993","journal-title":"Thorax"},{"key":"10.1124\/jpet.300.2.559_bib56","first-page":"73","article-title":"Cardiovascular cyclic nucleotide phosphodiesterases and their role in regulating cardiovascular function.","volume":"87","author":"Pagani","year":"1992","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/jpet.300.2.559_bib57","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1367-5931(98)80123-3","article-title":"Chemotherapeutic potential of phosphodiesterase inhibitors.","volume":"2","author":"Perry","year":"1998","journal-title":"Curr Opin Chem Biol"},{"key":"10.1124\/jpet.300.2.559_bib58","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0223-5234(00)00179-3","article-title":"Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies.","volume":"35","author":"Piaz","year":"2000","journal-title":"Eur J Med Chem"},{"key":"10.1124\/jpet.300.2.559_bib59","first-page":"1093","article-title":"Resistance of the alveolar epithelium to injury from septic shock in sheep.","volume":"151","author":"Pittet","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.300.2.559_bib60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0954-6111(99)90077-X","article-title":"The differential effect of pentoxifylline on cytokine production by alveolar macrophages and its clinical implications.","volume":"93","author":"Poulakis","year":"1999","journal-title":"Respir Med"},{"key":"10.1124\/jpet.300.2.559_bib61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-2999(00)00443-X","article-title":"Amrinone reduces ischaemia-reperfusion injury in rat heart.","volume":"402","author":"Rechtman","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.300.2.559_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2362.1998.00257.x","article-title":"Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn\u2019s disease and ulcerative colitis.","volume":"28","author":"Reimund","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1124\/jpet.300.2.559_bib63","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/thx.53.3.200","article-title":"New ideas on the pathophysiology and treatment of lung disease.","volume":"53","author":"Rogers","year":"1998","journal-title":"Thorax"},{"key":"10.1124\/jpet.300.2.559_bib64","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1651-2227.1997.tb14897.x","article-title":"Bronchopulmonary dysplasia and oxidative stress: are we closer to an understanding of the pathogenesis of BPD?","volume":"86","author":"Saugstad","year":"1997","journal-title":"Acta Pediatric"},{"key":"10.1124\/jpet.300.2.559_bib65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0192-0561(93)90052-Z","article-title":"The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-\u03b1 production by human mononuclear cells.","volume":"15","author":"Semmler","year":"1993","journal-title":"Int J Immunopharmacol"},{"key":"10.1124\/jpet.300.2.559_bib66","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1165\/ajrcmb.20.1.3278","article-title":"The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects.","volume":"20","author":"Smith","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/jpet.300.2.559_bib67","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/BF02044112","article-title":"Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock.","volume":"22","author":"Staudinger","year":"1996","journal-title":"Int Care Med"},{"key":"10.1124\/jpet.300.2.559_bib68","first-page":"402","article-title":"Mitogen-activated protein kinase cascades and regulation of gene expression.","volume":"8","author":"Su","year":"1996","journal-title":"Curr Biol"},{"key":"10.1124\/jpet.300.2.559_bib69","first-page":"1","article-title":"Serum concentrations of pentoxifylline and its metabolites in premature infants with sepsis when administered by continuous intravenous infusion.","volume":"3","author":"Szymura-Oleksiak","year":"1997","journal-title":"Pharm Sci"},{"key":"10.1124\/jpet.300.2.559_bib70","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1183\/09031936.95.08010127","article-title":"Immunological functions of the pulmonary epithelium.","volume":"8","author":"Thompson","year":"1985","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.300.2.559_bib71","doi-asserted-by":"crossref","first-page":"23598","DOI":"10.1074\/jbc.270.40.23598","article-title":"Salbutamol up-regulates PDE4 activity and induces a heterologous desensitization of U937 cells to prostaglandin-E2: implications for the therapeutic use of \u03b2-adrenoreceptor agonists.","volume":"270","author":"Torphy","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.300.2.559_bib72","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1172\/JCI118788","article-title":"Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types 3 and 4.","volume":"98","author":"Tsuboi","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.300.2.559_bib73","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0022-3565(24)37892-9","article-title":"Anti-asthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB-207499 (Ariflo) in the Guinea pig.","volume":"287","author":"Underwood","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.300.2.559_bib74","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2567.1997.00252.x","article-title":"Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-\u03b1, IL-1\u03b2 and IL-10 by human leukocytes.","volume":"91","author":"van Furth","year":"1997","journal-title":"Immunology"},{"key":"10.1124\/jpet.300.2.559_bib75","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood.V91.11.4255","article-title":"Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro.","volume":"91","author":"Visser","year":"1998","journal-title":"Blood"},{"key":"10.1124\/jpet.300.2.559_bib76","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","article-title":"Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.","volume":"34","author":"Ward","year":"1987","journal-title":"Drugs"},{"key":"10.1124\/jpet.300.2.559_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1843.2001.00289.x","article-title":"Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment.","volume":"6","author":"Wark","year":"2001","journal-title":"Respirology"},{"key":"10.1124\/jpet.300.2.559_bib78","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0076-6879(88)59048-1","article-title":"Methyxanthine inhibitors of phosphodiesterases.","volume":"159","author":"Wells","year":"1988","journal-title":"Methods Enzymol"},{"key":"10.1124\/jpet.300.2.559_bib79","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-3083.2000.00689.x","article-title":"Genes, receptors, signals and responses to lipopolysaccharide endotoxin.","volume":"51","author":"Wong","year":"2000","journal-title":"Scand J Immunol"},{"key":"10.1124\/jpet.300.2.559_bib80","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00063198-199605000-00002","article-title":"Pathogenesis of respiratory infections and host defenses.","volume":"2","author":"Zeiher","year":"1996","journal-title":"Curr Opin Pulm Med"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524354862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524354862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.300.2.559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:13:56Z","timestamp":1740006836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524354862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0022356524354862"],"URL":"https:\/\/doi.org\/10.1124\/jpet.300.2.559","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunopharmacological Potential of Selective Phosphodiesterase Inhibition. I. Differential Regulation of Lipopolysaccharide-Mediated Proinflammatory Cytokine (Interleukin-6 and Tumor Necrosis Factor-\u03b1) Biosynthesis in Alveolar Epithelial Cells","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.300.2.559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}